Which mutation is most commonly found in melanoma?

Study for the Pharmacology Presentation Drugs Test. Delve into flashcards and multiple choice questions with hints and explanations. Gear up for examination success!

Multiple Choice

Which mutation is most commonly found in melanoma?

Explanation:
Activating mutations in the MAPK signaling pathway are common in melanoma, and the most frequent event is a substitution at BRAF codon 600. The BRAF V600E mutation makes the BRAF kinase constitutively active, driving continuous MEK-ERK signaling and promoting melanoma cell growth without needing upstream signals. Because this mutation appears in roughly half of melanomas, it defines the dominant molecular subset and explains why targeted therapies against BRAF (often with MEK inhibitors) are effective. Other mutations like NRAS occur less often, KIT mutations are relatively rare and tied to specific melanoma subtypes, and PTEN loss is a tumor suppressor change that doesn’t account for the majority of cases.

Activating mutations in the MAPK signaling pathway are common in melanoma, and the most frequent event is a substitution at BRAF codon 600. The BRAF V600E mutation makes the BRAF kinase constitutively active, driving continuous MEK-ERK signaling and promoting melanoma cell growth without needing upstream signals. Because this mutation appears in roughly half of melanomas, it defines the dominant molecular subset and explains why targeted therapies against BRAF (often with MEK inhibitors) are effective. Other mutations like NRAS occur less often, KIT mutations are relatively rare and tied to specific melanoma subtypes, and PTEN loss is a tumor suppressor change that doesn’t account for the majority of cases.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy